Agenda for October 2025 Cancer Treatments Advisory Committee (CTAC) meeting
Source: PHARMAC Information on what the Cancer Treatments Advisory Committee (CTAC) will be considering at its half-day meeting in October 2025. Applications CTAC will discuss three applications for different treatments for a type of blood cancer, diffuse large B-cell lymphoma (DLBCL). Diffuse large B-cell lymphoma is a fast-growing blood cancer that starts in white blood … Read more